↓ Skip to main content

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model

Overview of attention for article published in JAMA Oncology, July 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
17 news outlets
blogs
7 blogs
policy
1 policy source
twitter
196 X users
facebook
3 Facebook pages
googleplus
2 Google+ users

Citations

dimensions_citation
220 Dimensions

Readers on

mendeley
287 Mendeley